Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care

Mindray Algeria Bahrain Egypt Iran Iraq Jordan Kuwait Lebanon Libya Morocco Oman Qatar Saudi Arabia Syria Tunisia United Arab Emirates Yemen Angola Botswana Ethiopia Gambia Ghana Guinea-Bissau Kenya Lesotho Liberia Malawi Maldives Mozambique Namibia Nigeria Sierra Leone Somalia South Africa Swaziland Tanzania Uganda Zambia Zimbabwe New Jersey Israel

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/mindray-expands-its-cardiac-biomarker-portfolio-with-cutting-edge-hs-ctni-and-nt-probnp-assays-empowering-enhanced-cardiovascular-diseases-care-301964347.html